Vergelijking

Buserelin vs. Sincalide

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

57982-77-1

25126-32-3

Molecuulmassa

1239.42 g/mol

1143.29 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

Werkingsmechanisme

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Bewijsbasis

Hoogste bewijs

Humane RCT

Humane studie

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Buserelin	Sincalide
Duitsland	Op recept	Onduidelijk
Verenigde Staten	Niet goedgekeurd	Op recept

Volledige vermeldingen

Buserelin

Volledige vermelding →

Sincalide

Volledige vermelding →

Frequently asked questions

What is the difference between Buserelin and Sincalide?: Buserelin is classified as "Onderzoek (overig)", while Sincalide is classified as "Onderzoek (overig)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Sincalide?: The highest available evidence level is "Humane RCT" for Buserelin and "Humane studie" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Sincalide in Germany and the United States?: Duitsland: Buserelin — Op recept, Sincalide — Onduidelijk. Verenigde Staten: Buserelin — Niet goedgekeurd, Sincalide — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Sincalide

Duitsland

Op recept

Onduidelijk

Verenigde Staten

Niet goedgekeurd

Op recept

Frequently asked questions

What is the difference between Buserelin and Sincalide?

Buserelin is classified as "Onderzoek (overig)", while Sincalide is classified as "Onderzoek (overig)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Sincalide?

The highest available evidence level is "Humane RCT" for Buserelin and "Humane studie" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Sincalide in Germany and the United States?

Duitsland: Buserelin — Op recept, Sincalide — Onduidelijk. Verenigde Staten: Buserelin — Niet goedgekeurd, Sincalide — Op recept. These are factual summaries with source and review date on the individual pages.